VERU INC.VERUEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Veru Inc. is a biopharmaceutical company focused on developing and commercializing innovative medicines for oncology, urology, and men’s and women’s health conditions. Its core product pipeline includes targeted therapies for breast and prostate cancer, as well as treatments for reproductive health disorders, serving patients primarily across North America and European markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Adage Capital Partners, L.P. | 9.50% | 13.7M | — | 2023-12-26 |
| BlackRock, Inc. | 5.60% | 8.2M | flat | 2024-11-08 |
| Adage Capital Management, L.P. | 5.37% | 7.9M | — | 2024-11-12 |
| Millennium Management LLC | 4.00% | 5.9M | ▼ -1.20pp | 2024-11-04 |
| Perceptive Advisors LLC | 3.80% | 5.6M | — | 2024-02-14 |
| Phillip Frost, M.D. | 3.50% | 5.1M | ▼ -2.20pp | 2024-02-06 |